Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
STRATTEC Security
STRT
$338M
| $516K | ﹤0.01% |
8,298
+5,646
| +213% | +$261K |
|
3677
LCNB Corp
LCNB
$285M
| $516K | ﹤0.01% |
35,485
+9,668
| +37% | +$140K |
|
3678
Gevo
GEVO
$401M
| $514K | ﹤0.01% |
389,455
+179,055
| +85% | +$210K |
|
3679
Ranger Energy Services
RNGR
$405M
| $512K | ﹤0.01% |
42,853
+12,742
| +42% | +$153K |
|
3680
Absci
ABSI
$1.62B
| $511K | ﹤0.01% |
198,877
+94,321
| +90% | +$266K |
|
3681
Liberty Global Class C
LBTYK
$3.48B
| $510K | ﹤0.01% |
49,468
+4,587
| +10% | +$47.5K |
|
3682
Citizens
CIA
$198M
| $510K | ﹤0.01% |
146,031
+23,154
| +19% | +$90.5K |
|
3683
Aquestive Therapeutics
AQST
$533M
| $509K | ﹤0.01% |
153,828
+70,871
| +85% | +$203K |
|
|
AVR
3684
Anteris Technologies
AVR
$870M
| $509K | ﹤0.01% |
134,304
+21,098
| +19% | +$85.8K |
|
3685
Global Water Resources
GWRS
$256M
| $508K | ﹤0.01% |
49,888
+11,500
| +30% | +$118K |
|
3686
MasterCraft Boat Holdings
MCFT
$598M
| $508K | ﹤0.01% |
27,355
-2,680
| -9% | -$45.8K |
|
3687
CALL
DuPont de Nemours
DD
$19.5B
| $508K | ﹤0.01% |
+5,895
| New | +$490K |
|
3688
Fate Therapeutics
FATE
$294M
| $507K | ﹤0.01% |
453,072
+85,787
| +23% | +$99.7K |
|
3689
CALL
Elevance Health
ELV
$86.4B
| $506K | ﹤0.01% |
1,300
-11,100
| -90% | -$4.46M |
|
3690
Kaltura
KLTR
$243M
| $505K | ﹤0.01% |
251,488
+40,847
| +19% | +$84.6K |
|
|
LINE
3691
Lineage Inc
LINE
$9.8B
| $504K | ﹤0.01% |
11,589
+3,533
| +44% | +$171K |
|
3692
Global X Uranium ETF
URA
$6.31B
| $504K | ﹤0.01% |
12,985
-73,422
| -85% | -$2.13M |
|
3693
Microvision
MVIS
$89.7M
| $503K | ﹤0.01% |
29,393
+11,199
| +62% | +$194K |
|
3694
Mama's Creations
MAMA
$790M
| $501K | ﹤0.01% |
60,363
+24,552
| +69% | +$177K |
|
3695
CALL
US Bancorp
USB
$102B
| $498K | ﹤0.01% |
11,000
+5,000
| +83% | +$210K |
|
3696
Paysign
PAYS
$735M
| $497K | ﹤0.01% |
68,966
+27,862
| +68% | +$99.8K |
|
3697
NRC Health Common Stock
NRC
$471M
| $495K | ﹤0.01% |
29,435
+6,852
| +30% | +$92.6K |
|
|
WOW
3698
DELISTED
WideOpenWest
WOW
| $491K | ﹤0.01% |
120,886
+34,861
| +41% | +$149K |
|
3699
Invesco DB Commodity Index Tracking Fund
DBC
$1.71B
| $490K | ﹤0.01% |
22,469
-494
| -2% | -$10.6K |
|
|
RZLV
3700
Rezolve AI
RZLV
$1.06B
| $489K | ﹤0.01% |
+158,876
| New | +$313K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.